Aortic intramural haematoma: current therapeutic strategy

Over the last 10 years, intramural haematoma (IMH) of the aorta has become increasingly recognised as a pathological entity distinct from aortic dissection.1 Despite this enhanced appreciation and the resultant increase in the frequency of its diagnostic identification, a consensus regarding optimal management strategies for this disease has not been established.2 This is due in part to our incomplete understanding of a condition only first...